Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Zhongxing BioTech(002772) the Revenue is 601.97 M (+27.36%);the EBIT is 173.41 M (+226.6%);the EPS is 0.426 (+232.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.60B27.36%
----
----
EBIT
0.17B226.56%
----
----
EPS
0.4264232.09%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf